Global Healthcare Nanotechnology (Nanomedicine) Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 3128

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.
The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.
In 2018, the global Healthcare Nanotechnology (Nanomedicine) market size was 160800 million US$ and it is expected to reach 306100 million US$ by the end of 2025, with a CAGR of 9.6% during 2019-2025.

This report focuses on the global Healthcare Nanotechnology (Nanomedicine) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Healthcare Nanotechnology (Nanomedicine) development in United States, Europe and China.

The key players covered in this study
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International

Market segment by Type, the product can be split into
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other

Market segment by Application, split into
Anticancer
CNS Product
Anti-infective
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Healthcare Nanotechnology (Nanomedicine) status, future forecast, growth opportunity, key market and key players.
To present the Healthcare Nanotechnology (Nanomedicine) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Healthcare Nanotechnology (Nanomedicine) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type (2014-2025)
1.4.2 Nanomedicine
1.4.3 Nano Medical Devices
1.4.4 Nano Diagnosis
1.4.5 Other
1.5 Market by Application
1.5.1 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2014-2025)
1.5.2 Anticancer
1.5.3 CNS Product
1.5.4 Anti-infective
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Healthcare Nanotechnology (Nanomedicine) Market Size
2.2 Healthcare Nanotechnology (Nanomedicine) Growth Trends by Regions
2.2.1 Healthcare Nanotechnology (Nanomedicine) Market Size by Regions (2014-2025)
2.2.2 Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Healthcare Nanotechnology (Nanomedicine) Market Size by Manufacturers
3.1.1 Global Healthcare Nanotechnology (Nanomedicine) Revenue by Manufacturers (2014-2019)
3.1.2 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio (CR5 and HHI)
3.2 Healthcare Nanotechnology (Nanomedicine) Key Players Head office and Area Served
3.3 Key Players Healthcare Nanotechnology (Nanomedicine) Product/Solution/Service
3.4 Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2014-2019)
4.2 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2014-2019)

5 United States
5.1 United States Healthcare Nanotechnology (Nanomedicine) Market Size (2014-2019)
5.2 Healthcare Nanotechnology (Nanomedicine) Key Players in United States
5.3 United States Healthcare Nanotechnology (Nanomedicine) Market Size by Type
5.4 United States Healthcare Nanotechnology (Nanomedicine) Market Size by Application

6 Europe
6.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size (2014-2019)
6.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Europe
6.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type
6.4 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application

7 China
7.1 China Healthcare Nanotechnology (Nanomedicine) Market Size (2014-2019)
7.2 Healthcare Nanotechnology (Nanomedicine) Key Players in China
7.3 China Healthcare Nanotechnology (Nanomedicine) Market Size by Type
7.4 China Healthcare Nanotechnology (Nanomedicine) Market Size by Application

8 Japan
8.1 Japan Healthcare Nanotechnology (Nanomedicine) Market Size (2014-2019)
8.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Japan
8.3 Japan Healthcare Nanotechnology (Nanomedicine) Market Size by Type
8.4 Japan Healthcare Nanotechnology (Nanomedicine) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size (2014-2019)
9.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Southeast Asia
9.3 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size by Type
9.4 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size by Application

10 India
10.1 India Healthcare Nanotechnology (Nanomedicine) Market Size (2014-2019)
10.2 Healthcare Nanotechnology (Nanomedicine) Key Players in India
10.3 India Healthcare Nanotechnology (Nanomedicine) Market Size by Type
10.4 India Healthcare Nanotechnology (Nanomedicine) Market Size by Application

11 Central & South America
11.1 Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size (2014-2019)
11.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Central & South America
11.3 Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size by Type
11.4 Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size by Application

12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.1.4 Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Teva Pharmaceuticals
12.2.1 Teva Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.2.5 Teva Pharmaceuticals Recent Development
12.3 Abbott
12.3.1 Abbott Company Details
12.3.2 Company Description and Business Overview
12.3.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.3.4 Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.3.5 Abbott Recent Development
12.4 UCB
12.4.1 UCB Company Details
12.4.2 Company Description and Business Overview
12.4.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.4.4 UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.4.5 UCB Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.5.4 Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Celgene
12.6.1 Celgene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.6.4 Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.6.5 Celgene Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.7.4 Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Merck & Co
12.8.1 Merck & Co Company Details
12.8.2 Company Description and Business Overview
12.8.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.8.4 Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.8.5 Merck & Co Recent Development
12.9 Biogen
12.9.1 Biogen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.9.4 Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.9.5 Biogen Recent Development
12.10 Stryker
12.10.1 Stryker Company Details
12.10.2 Company Description and Business Overview
12.10.3 Healthcare Nanotechnology (Nanomedicine) Introduction
12.10.4 Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2014-2019)
12.10.5 Stryker Recent Development
12.11 Gilead Sciences
12.12 Pfizer
12.13 3M Company
12.14 Johnson & Johnson
12.15 Smith & Nephew
12.16 Leadiant Biosciences
12.17 Kyowa Hakko Kirin
12.18 Shire
12.19 Ipsen
12.20 Endo International

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details